Crossmark

Phenolic compounds and chemotherapeutic agents differentially regulate P2X receptor subtypes in malignant melanoma

Published Online: 2026-03-12

Published Print: 2026-04

Authors

Sen, Serkan https://orcid.org/0000-0002-2884-4753
Celik, Sefa https://orcid.org/0000-0002-5187-378X
License Information

Text and Data Mining valid from 2026-03-12

Version of Record valid from 2026-03-12
More Information

Article History

Received: 30 October 2025

Accepted: 4 March 2026

First Online: 12 March 2026

Declarations

:

: The authors declare that they have no competing interests.

: The authors declare no competing interests.

Document is current